January 30, 2019
Feasibility Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Read More
January 30, 2019
Feasibility Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Read More
December 10, 2018
Immunogenicity and Safety of GSK Biologicals’ Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Read More
X